Ayesh S, Shao Y M, Stein W D
Silberman Institute of Life Sciences, Hebrew University, Jerusalem, Israel.
Biochim Biophys Acta. 1996 May 24;1316(1):8-18. doi: 10.1016/0925-4439(96)00008-7.
We measured the effects of individual modulators and of pairs of modulators of the multidrug resistance pump, P-glycoprotein, on the accumulation of labelled daunomycin into multidrug-resistant P388 leukemia cells at 37 degrees C and developed a kinetic analysis which enables such data to be modelled in terms of co-operative, competitive or non-competitive interaction between pairs of modulators. The modulators verapamil, cyclosporin and trifluoperazine interacted with P-glycoprotein as single molecules, while vinblastine, mefloquine, dipyridamole, tamoxifen and quinidine displayed Hill numbers close to 2, suggesting that pairs of modulator molecules need to act together in order to bring about effective reversal of P-glycoprotein. When the modulators were presented to P-glycoprotein in pairs, we found examples of both competitive and non-competitive behaviour. We interpret these results on a model in which two modulatory sites exit on the MDR pump. To one of these, mefloquine, vinblastine and tamoxifen bind preferentially; to the other, verapamil, dipyridamole, trifluoperazine and quinidine bind (but mefloquine and tamoxifen only weakly if at all). Cyclosporin A can interact with both sites.
我们测定了多药耐药泵P-糖蛋白的单个调节剂以及调节剂对在37℃下标记柔红霉素在多药耐药P388白血病细胞中的蓄积的影响,并开展了一项动力学分析,该分析能够根据调节剂对之间的协同、竞争或非竞争相互作用对这类数据进行建模。调节剂维拉帕米、环孢素和三氟拉嗪作为单个分子与P-糖蛋白相互作用,而长春碱、甲氟喹、双嘧达莫、他莫昔芬和奎尼丁的希尔系数接近2,这表明调节剂分子对需要共同作用才能有效逆转P-糖蛋白。当将调节剂对呈现给P-糖蛋白时,我们发现了竞争和非竞争行为的实例。我们在一个模型中解释这些结果,该模型中多药耐药泵上存在两个调节位点。甲氟喹、长春碱和他莫昔芬优先结合其中一个位点;维拉帕米、双嘧达莫、三氟拉嗪和奎尼丁结合另一个位点(但甲氟喹和他莫昔芬即便结合也很弱)。环孢素A可与两个位点相互作用。